Bone and Joint Therapeutics CEO Merrimack Pharmaceuticals
Merrimack Pharmaceuticals is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. Merrimack applies Network Biology, its proprietary systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has six targeted therapeutic oncology candidates in clinical development.
We are looking for a passionate individual to build and lead a company focused on therapeutic approaches to musculoskeletal disorders. Merrimack has developed novel therapeutic approaches designed to improve outcomes for patients with joint degradation or tumors of the bone. Merrimack intends to spin out a new company that will focus on drug discovery and development of novel, systems biology derived therapeutics to improve musculoskeletal disorders. Our goal is to cure or significantly delay skeletal deterioration for patients. These drugs would benefit a wide range of patients from hyperactive adolescents to athletes to the elderly. We are looking for a CEO for this new venture to provide strategic, financial and operational leadership as the company positions itself to spin out and build a trajectory as an independent enterprise.
The ideal candidate will be:
An engineer at heart ?driven to treat musculoskeletal disorders as a systems disease
Passionate about multi-dimensional drugs
Eager to change the status quo
Willing to assess and take risk in charting a path for clinical development
Great at developing high-performing and committed teams
We will also weigh:
Experience in this therapeutic space or similar experience
Experience in building early or middle-stage businesses
Experience in raising capital and/or structuring joint ventures
||One Kendall Square |
Building 700, Second Floor
Cambridge, MA 02139